Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,521.73
(
0.65%
)
US TECH 100
29,222.80
(
1.82%
)
Dow Jones
50,425.18
(
-0.31%
)
Brent Oil
96.68
(
-4.44%
)
Bitcoin
75,981.98
(
-1.67%
)
News Focus
News Focus
Post# of 827667
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

john1045

Send PM Follow Ignore
Followers 36
Posts 2691
Boards Moderated 0
Alias Born 06/09/2011

john1045

Re: ou71764 post# 4226

Saturday, 02/08/2014 11:55:26 AM

Saturday, February 08, 2014 11:55:26 AM

Post# of 827667
The poster is welcome to his own personal thoughts on why NWBO approach is better or worse. I respectfully and personally do not agree with that poster on targeting one antigen against cancer.

In all of my own due diligence I believe the DCVax approach using all of the antigens and biomarkers of the tumor will be most successful in the fight against both operable and inoperable solid tumor cancers.

We will find out soon enough with 1st interim results due any day as well as an update DCVax-Direct. Thank you.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News